Grace Therapeutics, Inc. (ACST)
2.12
+0.02
(+0.95%)
USD |
NASDAQ |
Sep 08, 16:00
Grace Therapeutics Shareholders Equity (Quarterly) : 48.21M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.21M |
| March 31, 2026 | 63.90M |
| December 31, 2025 | 64.89M |
| September 30, 2025 | 62.82M |
| June 30, 2025 | 63.55M |
| March 31, 2025 | 66.61M |
| December 31, 2024 | 52.14M |
| September 30, 2024 | 56.13M |
| June 30, 2024 | 59.36M |
| March 31, 2024 | 61.74M |
| December 31, 2023 | 64.68M |
| September 30, 2023 | 66.74M |
| June 30, 2023 | 64.01M |
| March 31, 2023 | 67.96M |
| December 31, 2022 | 96.72M |
| September 30, 2022 | 100.16M |
| June 30, 2022 | 104.40M |
| March 31, 2022 | 108.27M |
| December 31, 2021 | 111.06M |
| September 30, 2021 | 114.20M |
| June 30, 2021 | 53.46M |
| March 31, 2021 | 55.66M |
| December 31, 2020 | 25.72M |
| September 30, 2020 | 8.873M |
| June 30, 2020 | 11.04M |
| Date | Value |
|---|---|
| December 31, 2019 | -4.766M |
| September 30, 2019 | -1.261M |
| June 30, 2019 | 2.730M |
| March 31, 2019 | 10.45M |
| December 31, 2018 | 22.42M |
| September 30, 2018 | -11.47M |
| June 30, 2018 | 5.731M |
| March 31, 2018 | 6.379M |
| December 31, 2017 | 12.16M |
| September 30, 2017 | 11.84M |
| June 30, 2017 | 14.61M |
| November 30, 2016 | 14.70M |
| August 31, 2016 | 16.78M |
| May 31, 2016 | 18.45M |
| February 29, 2016 | 20.09M |
| November 30, 2015 | 21.80M |
| August 31, 2015 | 23.43M |
| May 31, 2015 | 25.91M |
| February 28, 2015 | 26.61M |
| November 30, 2014 | 31.03M |
| August 31, 2014 | 29.58M |
| May 31, 2014 | 32.58M |
| February 28, 2014 | 30.06M |
| November 30, 2013 | 19.39M |
| August 31, 2013 | 20.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Abeona Therapeutics, Inc. | 128.06M |
| America Great Health | -4.798M |
| Acumen Pharmaceuticals, Inc. | 57.26M |
| Aardvark Therapeutics, Inc. | 74.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 50.07M |
| Total Liabilities (Quarterly) | 1.862M |
| Current Ratio | 11.47 |